Anti-neurofilament antibodies and neurodegeneration: Markers and generators

Lu, 2010, Anti-α-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis, PLoS One, 5, 10.1371/journal.pone.0011124 Al-Chalabi, 2016, Amyotrophic lateral sclerosis: moving towards a new classification system, Lancet Neurol., 10.1016/S1474-4422(16)30199-5 Bahmanyar, 1984, Characterization of Antineurofilament autoantibodies in Creutzfeldt-Jakob disease, J. Neuropathol. Exp. Neurol., 43, 369, 10.1097/00005072-198407000-00002 Barry, 2012, Expansion of neurofilament medium C terminus increases axonal diameter independent of increases in conduction velocity or myelin thickness, J. Neurosci., 32, 6209, 10.1523/JNEUROSCI.0647-12.2012 Bartoš, 2007, Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis, J. Neurol., 254, 20, 10.1007/s00415-006-0185-0 Bartos, 2012, Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament, J. Neuroimmunol., 252, 100, 10.1016/j.jneuroim.2012.08.001 Bartos, 2012, P2-050: lower serum antibodies against tau protein and heavy neurofilament in Alzheimer’s disease, Alzheimers Dement., 8, P280, 10.1016/j.jalz.2012.05.2144 Bartos, 2018, Lower serum antibodies against tau protein and heavy neurofilament in Alzheimer’s disease, J. Alzheimers Dis., 64, 751, 10.3233/JAD-180039 Basal, 2018, Paraneoplastic neuronal intermediate filament autoimmunity, Neurology, 91, E1677, 10.1212/WNL.0000000000006435 Braun, 1982, Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy, J. Neurochem., 39, 1261, 10.1111/j.1471-4159.1982.tb12563.x Brettschneider, 2006, Axonal damage markers in cerebrospinal fluid are increased in ALS, Neurology, 66, 852, 10.1212/01.wnl.0000203120.85850.54 Brownlee, 2017, Diagnosis of multiple sclerosis: progress and challenges, Lancet., 10.1016/S0140-6736(16)30959-X Chamberlain, 2010, Peripherin-IgG association with neurologic and endocrine autoimmunity, J. Autoimmun., 34, 469, 10.1016/j.jaut.2009.12.004 Chapman, 1988, Antibodies to cholinergic neurons in Alzheimer’s disease, J. Neurochem., 51, 479, 10.1111/j.1471-4159.1988.tb01063.x Chapman, 1989, Alzheimer’s disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons, J. Neurosci., 9, 2710, 10.1523/JNEUROSCI.09-08-02710.1989 Chapman, 1991, Anti-neuronal antibodies similar to those found in Alzheimer’s disease induce memory dysfunction in rats, Neuroscience, 40, 297, 10.1016/0306-4522(91)90121-4 Colasanti, 2009, Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus, J. Neuroimmunol., 10.1016/j.jneuroim.2009.05.003 Dalakas, 1986, A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms, N. Engl. J. Med., 314, 959, 10.1056/NEJM198604103141505 Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol., 7, 1091, 10.1016/S1474-4422(08)70224-2 Desai, 1994, Detection of autoantibodies to neural antigens in the CSF of Japanese encephalitis patients and correlation of findings with the outcome, J. Neurol. Sci., 122, 109, 10.1016/0022-510X(94)90060-4 Disanto, 2012, The evidence for a role of B cells in multiple sclerosis, Neurology., 10.1212/WNL.0b013e318249f6f0 Disanto, 2017, Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis, Ann. Neurol., 81, 857, 10.1002/ana.24954 Drory, 1998, Antineurofilament antibodies in postpolio syndrome, Neurology, 51, 1193, 10.1212/WNL.51.4.1193 Dujmovic, 2011, Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis, Mult. Scler. Int., 2011 Ehling, 2004, Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis, Mult. Scler. J., 10, 601, 10.1191/1352458504ms1100oa Eikelenboom, 2003, Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy, Neurology, 60, 219, 10.1212/01.WNL.0000041496.58127.E3 Engelhardt, 2005, Subcellular localization of IgG from the sera of ALS patients in the nervous system, Acta Neurol. Scand., 112, 126, 10.1111/j.1600-0404.2005.00445.x Fang, 2016, Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis, JAMA Neurol., 73, 1297, 10.1001/jamaneurol.2016.2549 Fialová, 2013, Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis, J. Neuroimmunol., 259, 81, 10.1016/j.jneuroim.2013.03.009 Flanagan, 2017, Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients, Ann. Neurol., 81, 298, 10.1002/ana.24881 Fortea, 2018, Plasma and CSF biomarkers for the diagnosis of Alzheimer’s disease in adults with down syndrome: a cross-sectional study, Lancet Neurol., 17, 860, 10.1016/S1474-4422(18)30285-0 Fraussen, 2016, B cells and antibodies in progressive multiple sclerosis: contribution to neurodegeneration and progression, Autoimmun. Rev., 10.1016/j.autrev.2016.07.008 Gelfand, 2017, Ocrelizumab and other CD20+ B-cell-depleting therapies in multiple sclerosis, Neurotherapeutics., 10.1007/s13311-017-0557-4 German, 2006, A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model, Trans. R. Soc. Trop. Med. Hyg., 100, 1135, 10.1016/j.trstmh.2006.02.008 Grönblad, 1988, Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis, J. Rheumatol., 15, 1807 Hammer, 1993, Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoprotens in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies, J. Neurosci. Res., 35, 546, 10.1002/jnr.490350511 Hassin-Baer, 1992, Antibodies from down’s syndrome patients bind to the same cholinergic neurofilament protein recognized by alzheimer’s disease antibodies, Neurology, 42, 551, 10.1212/WNL.42.3.551 Herrmann, 2016, Intermediate filaments: structure and assembly, Cold Spring Harb. Perspect. Biol., 8, a018242, 10.1101/cshperspect.a018242 Ho, 1998, Human autoimmune neuropathies, Annu. Rev. Neurosci., 21, 187, 10.1146/annurev.neuro.21.1.187 Kanitakis, 1998, Expression of the intermediate filament peripherin in skin tumors, Eur. J. Dermatol., 8, 339 Karcher, 1986, Anti-neurofilament antibodies in blood of patients with neurological diseases, Acta Neuropathol., 72, 82, 10.1007/BF00687951 Khalil, 2018, Neurofilaments as biomarkers in neurological disorders, Nat. Rev. Neurol., 10.1038/s41582-018-0058-z Kirkcaldie, 2017, The third wave: intermediate filaments in the maturing nervous system, Mol. Cell. Neurosci., 10.1016/j.mcn.2017.05.010 Kornguth, 2017, Neurofilament protein and antineurofilament antibodies following traumatic brain injury, JAMA Neurol., 10.1001/jamaneurol.2016.5908 Kornguth, 1986, Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome, Cancer Res., 46, 2588 Kurki, 1986, Neurofilament antibodies in systemic lupus erythematosus, J. Rheumatol., 13, 69 Levin, 2010, Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown, Brain Res., 1345, 221, 10.1016/j.brainres.2010.05.038 Liu, 2014, α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness, J. Clin. Endocrinol. Metab., 99, E786, 10.1210/jc.2013-2874 Lu, 2011, A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect, J. Neurosci. Methods, 195, 143, 10.1016/j.jneumeth.2010.11.026 Lu, 2012 Lycke, 1998, Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 64, 402, 10.1136/jnnp.64.3.402 Mackenzie, 2017, Creutzfeldt-Jakob disease: recent developments, F1000Research, 10.12688/f1000research.12681.1 Mattsson, 2017, Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease, JAMA Neurol., 74, 557, 10.1001/jamaneurol.2016.6117 McKeon, 2011, Paraneoplastic encephalomyelopathies: pathology and mechanisms. - PubMed - NCBI, Acta Neuropathol., 122, 381, 10.1007/s00401-011-0876-1 Molenaar, 1999, Expression of neural cell adhesion molecules and neurofilament protein isoforms in Ewing’s sarcoma of bone and soft tissue sarcomas other than rhabdomyosarcoma, Hum. Pathol., 30, 1207, 10.1016/S0046-8177(99)90039-4 Muscal, 2010, Neurologic manifestations of systemic lupus erythematosus in children and adults, Neurol. Clin., 10.1016/j.ncl.2009.09.004 Nakazato, 1990, Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phosphorylated Neurofilament epitope, J. Neuropathol. Exp. Neurol., 49, 197, 10.1097/00005072-199005000-00001 Neff, 2008, Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders, Autoimmun. Rev., 10.1016/j.autrev.2008.04.010 Nixon, 1991, Neurofilament phosphorylation: a new look at regulation and function, Trends Neurosci., 10.1016/0166-2236(91)90062-Y Oron, 1994, Model studies of the role of anti-Neurofilament antibodies in neurodegeneration in Alzheimer’s disease, 395 Oron, 1997, Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer’s disease, J. Neural Transm. Suppl. Puentes, 2014, Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, 85, 274, 10.1136/jnnp-2013-305494 Pullen, 2004, Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement, Acta Neuropathol., 107, 35, 10.1007/s00401-003-0777-z Quarles, 1999, Autoantibodies associated with peripheral neuropathy, Muscle Nerve, 22, 800, 10.1002/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F Rajasalu, 2004, Demonstration of natural autoantibodies against the neurofilament protein α-internexin in sera of patients with endocrine autoimmunity and healthy individuals, Immunol. Lett., 94, 153, 10.1016/j.imlet.2004.05.002 Rao, 2003, The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate, J. Cell Biol., 163, 1021, 10.1083/jcb.200308076 Rosengren, 1999, Neurofilament protein levels in CSF are increased in dementia, Neurology, 52, 1090, 10.1212/WNL.52.5.1090 Rosengren, 2002, Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of Neurofilament protein in CSF, J. Neurochem., 67, 2013, 10.1046/j.1471-4159.1996.67052013.x Rosenmann, 2006, Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer’s disease and healthy subjects, Neurosci. Lett., 410, 90, 10.1016/j.neulet.2006.01.072 Salihl, 1998, Prevalence of antibodies to neurofilament polypeptides in patients with rheumatoid arthritis complicated by peripheral neuropathy, Clin. Exp. Rheumatol., 16, 689 Silber, 2002, Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit, Neurology, 58, 1372, 10.1212/WNL.58.9.1372 Sjögren, 2000, Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD, Neurology, 54, 1960, 10.1212/WNL.54.10.1960 Soussan, 1994, Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer’s disease, Mol. Neurobiol., 9, 83, 10.1007/BF02816107 Soussan, 2002, Distinctly phosphorylated neurofilaments in different classes of neurons, J. Neurochem., 62, 770, 10.1046/j.1471-4159.1994.62020770.x Stubbs, 2003, Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block, Acta Neuropathol., 105, 109, 10.1007/s00401-002-0615-8 Toh, 1985, The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease and other neurologic diseases, Proc. Natl. Acad. Sci. U. S. A., 82, 3485, 10.1073/pnas.82.10.3485 Trojanowski, 1986, Expression of neurofilament subunits in neurons of the central and peripheral nervous system: an immunohistochemical study with monoclonal antibodies, J. Neurosci., 6, 650, 10.1523/JNEUROSCI.06-03-00650.1986 Trysberg, 2003, Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement, Arthritis Rheum., 48, 2881, 10.1002/art.11279 Voshol, 1996, Structure of the HNK-1 carbohydrate epitope on bovine peripheral myelin glycoprotein P0, J. Biol. Chem., 271, 22957, 10.1074/jbc.271.38.22957 Yuan, 2016, Specialized roles of neurofilament proteins in synapses: relevance to neuropsychiatric disorders, Brain Res. Bull., 10.1016/j.brainresbull.2016.09.002 Zandman-Goddard, 2007, Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome, Semin. Arthritis Rheum., 36, 297, 10.1016/j.semarthrit.2006.11.003